Carcinoembryonic antigen (CEA) is a tumor marker for the most common forms of adenocarcinomas. We have previously described C57BL/6 mice transgenic for the complete human CEA gene. Compared with humans, these mice reveal a conserved spatiotemporal CEA expression pattern. To establish animal models f
An in-vitro model for tumor immunotherapy with antibody heteroconjugates
✍ Scribed by Gundram Jung; Hans J. Müller Eberhard
- Publisher
- Elsevier Science
- Year
- 1988
- Tongue
- English
- Weight
- 594 KB
- Volume
- 9
- Category
- Article
- ISSN
- 0167-5699
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Genetically modified natural killer (NK) cells that recognize tumor‐associated surface antigens have recently shown promise as a novel approach for cancer immunotherapy. To determine NK cell therapy response early, a real‐time, noninvasive method to quantify NK cell homing to the tumor
## Abstract We developed a method for evaluating tumor glycolytic rates in vivo with nude mice injected with 2‐[F‐18]fluoro‐2‐deoxy‐d‐glucose (FDG) and a dedicated animal positron emission tomography (PET) scanner. Animals were injected with NR‐6 mouse fibroblast tumor cell lines. When tumors achie
## Abstract Both melanoma and glioma cells are of neuroectodermal origin and share common tumor associated antigens. In this article, we report that the melanocyte differentiation antigen TRP2 (tyrosinase‐related protein 2) is not predominately involved in the tumor rejection of a syngeneic murine